4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055068
Director sold 50,000 shares at an average $52.35 ($2,617,550)
- Director acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pellini Michael J Director | 2020-10-14 | Option exercise | +50,000 | $6.55 | $327,500 | 50,000 | D: show line 1 in the form |
| Pellini Michael J Director | 2020-10-14 | Sale | −28,255 | $51.89 | $1,466,152 | 21,745 | D: show line 2 in the form |
| Pellini Michael J Director | 2020-10-14 | Sale | −21,745 | $52.95 | $1,151,398 | 0 | D: show line 3 in the form |
| Open-market sales · 50,000 sh · avg $52.35 · $2,617,550 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pellini Michael J Director | 2020-10-14 | Option exercise · Stock Option (Right to Buy) | −50,000 | 100,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…